These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Identification of residues in the cysteine-rich domain of Raf-1 that control Ras binding and Raf-1 activity. Winkler DG; Cutler RE; Drugan JK; Campbell S; Morrison DK; Cooper JA J Biol Chem; 1998 Aug; 273(34):21578-84. PubMed ID: 9705288 [TBL] [Abstract][Full Text] [Related]
3. Interactions of the amino acid residue at position 31 of the c-Ha-Ras protein with Raf-1 and RalGDS. Shirouzu M; Morinaka K; Koyama S; Hu CD; Hori-Tamura N; Okada T; Kariya K; Kataoka T; Kikuchi A; Yokoyama S J Biol Chem; 1998 Mar; 273(13):7737-42. PubMed ID: 9516482 [TBL] [Abstract][Full Text] [Related]
4. Ras interaction with two distinct binding domains in Raf-1 may be required for Ras transformation. Drugan JK; Khosravi-Far R; White MA; Der CJ; Sung YJ; Hwang YW; Campbell SL J Biol Chem; 1996 Jan; 271(1):233-7. PubMed ID: 8550565 [TBL] [Abstract][Full Text] [Related]
5. Mutations in conserved regions 1, 2, and 3 of Raf-1 that activate transforming activity. Chan EY; Stang SL; Bottorff DA; Stone JC Mol Carcinog; 2002 Apr; 33(4):189-97. PubMed ID: 11933072 [TBL] [Abstract][Full Text] [Related]
6. The RafC1 cysteine-rich domain contains multiple distinct regulatory epitopes which control Ras-dependent Raf activation. Daub M; Jöckel J; Quack T; Weber CK; Schmitz F; Rapp UR; Wittinghofer A; Block C Mol Cell Biol; 1998 Nov; 18(11):6698-710. PubMed ID: 9774683 [TBL] [Abstract][Full Text] [Related]
7. Ras binding opens c-Raf to expose the docking site for mitogen-activated protein kinase kinase. Terai K; Matsuda M EMBO Rep; 2005 Mar; 6(3):251-5. PubMed ID: 15711535 [TBL] [Abstract][Full Text] [Related]
8. Differential structural requirements for interaction of Ras protein with its distinct downstream effectors. Akasaka K; Tamada M; Wang F; Kariya K; Shima F; Kikuchi A; Yamamoto M; Shirouzu M; Yokoyama S; Kataoka T J Biol Chem; 1996 Mar; 271(10):5353-60. PubMed ID: 8621388 [TBL] [Abstract][Full Text] [Related]
9. Point mutants of c-raf-1 RBD with elevated binding to v-Ha-Ras. Fridman M; Maruta H; Gonez J; Walker F; Treutlein H; Zeng J; Burgess A J Biol Chem; 2000 Sep; 275(39):30363-71. PubMed ID: 10887184 [TBL] [Abstract][Full Text] [Related]
10. Synthesis and biological evaluation of cycloalkylidene carboxylic acids as novel effectors of Ras/Raf interaction. Friese A; Hell-Momeni K; Zündorf I; Winckler T; Dingermann T; Dannhardt G J Med Chem; 2002 Mar; 45(7):1535-42. PubMed ID: 11906294 [TBL] [Abstract][Full Text] [Related]
11. Regulation of the protein kinase Raf-1 by oncogenic Ras through phosphatidylinositol 3-kinase, Cdc42/Rac and Pak. Sun H; King AJ; Diaz HB; Marshall MS Curr Biol; 2000 Mar; 10(5):281-4. PubMed ID: 10712905 [TBL] [Abstract][Full Text] [Related]
12. Microtubule integrity regulates Pak leading to Ras-independent activation of Raf-1. insights into mechanisms of Raf-1 activation. Zang M; Waelde CA; Xiang X; Rana A; Wen R; Luo Z J Biol Chem; 2001 Jul; 276(27):25157-65. PubMed ID: 11274179 [TBL] [Abstract][Full Text] [Related]
13. The strength of interaction at the Raf cysteine-rich domain is a critical determinant of response of Raf to Ras family small GTPases. Okada T; Hu CD; Jin TG; Kariya K; Yamawaki-Kataoka Y; Kataoka T Mol Cell Biol; 1999 Sep; 19(9):6057-64. PubMed ID: 10454553 [TBL] [Abstract][Full Text] [Related]
14. Structural determinants of Ras-Raf interaction analyzed in live cells. Bondeva T; Balla A; Várnai P; Balla T Mol Biol Cell; 2002 Jul; 13(7):2323-33. PubMed ID: 12134072 [TBL] [Abstract][Full Text] [Related]
15. In vitro inhibition of Ras-Raf association by short peptides. Barnard D; Sun H; Baker L; Marshall MS Biochem Biophys Res Commun; 1998 Jun; 247(1):176-80. PubMed ID: 9636675 [TBL] [Abstract][Full Text] [Related]
16. Effect of phosphorylation on activities of Rap1A to interact with Raf-1 and to suppress Ras-dependent Raf-1 activation. Hu CD; Kariya K; Okada T; Qi X; Song C; Kataoka T J Biol Chem; 1999 Jan; 274(1):48-51. PubMed ID: 9867809 [TBL] [Abstract][Full Text] [Related]
17. Inhibitors of Ras/Raf-1 interaction identified by two-hybrid screening revert Ras-dependent transformation phenotypes in human cancer cells. Kato-Stankiewicz J; Hakimi I; Zhi G; Zhang J; Serebriiskii I; Guo L; Edamatsu H; Koide H; Menon S; Eckl R; Sakamuri S; Lu Y; Chen QZ; Agarwal S; Baumbach WR; Golemis EA; Tamanoi F; Khazak V Proc Natl Acad Sci U S A; 2002 Oct; 99(22):14398-403. PubMed ID: 12391290 [TBL] [Abstract][Full Text] [Related]
18. Erythropoietin regulation of Raf-1 and MEK: evidence for a Ras-independent mechanism. Chen C; Sytkowski AJ Blood; 2004 Jul; 104(1):73-80. PubMed ID: 15026317 [TBL] [Abstract][Full Text] [Related]
19. Loss of Raf-1-binding activity of v-Ha-Ras by the deletion of amino acid residues 64-72 and 143-151. Hiwasa T; Kasama M; Nakadai T; Sawada T; Sakiyama S Cell Signal; 1996 Aug; 8(5):393-6. PubMed ID: 8911690 [TBL] [Abstract][Full Text] [Related]
20. Impaired binding of 14-3-3 to C-RAF in Noonan syndrome suggests new approaches in diseases with increased Ras signaling. Molzan M; Schumacher B; Ottmann C; Baljuls A; Polzien L; Weyand M; Thiel P; Rose R; Rose M; Kuhenne P; Kaiser M; Rapp UR; Kuhlmann J; Ottmann C Mol Cell Biol; 2010 Oct; 30(19):4698-711. PubMed ID: 20679480 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]